Clinical Trials Browser

Active not recruiting × adagrasib × 30 days × Clear all

NCT05722327 2026-03-04

Phase I Trial of Adagrasib (MRTX849) in Combination With Cetuximab and Irinotecan in Patients With Colorectal Cancer

Phase 1 Active not recruiting

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms